Last updated: February 3, 2021
Sponsor: Esperion Therapeutics, Inc.
Overall Status: Completed
Phase
3
Condition
Atherosclerosis
Vascular Diseases
Hypercholesterolemia
Treatment
N/AClinical Study ID
NCT03067441
1002-050
2016-004115-12
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Successfully completed CLEAR Harmony (1002-040) parent study
Exclusion
Exclusion Criteria:
- Experienced a treatment-related SAE that led to study drug discontinuation in theCLEAR Harmony (1002-040) parent study.
- Medical condition requires lipid measurement and/or adjustment of backgroundlipid-regulating therapy.
Study Design
Total Participants: 1462
Study Start date:
February 03, 2017
Estimated Completion Date:
November 05, 2019
Connect with a study center
Jedidiah Clinical Research
Tampa, Florida 33607
United StatesSite Not Available
L-MARC Research Center
Louisville, Kentucky 40213
United StatesSite Not Available
Sentral Clinical Research Services
Cincinnati, Ohio 45236
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.